| Company Name: |
Lynnchem |
| Tel: |
86-(0)29-85992781 17792393971 |
| Email: |
info@lynnchem.com |
- Chrysomycin A
-
-
2026-07-27
- CAS:82196-88-1
- Purity:
- Supply Ability: 10g
|
| | Chrysomycin A Basic information |
| Product Name: | Chrysomycin A | | Synonyms: | 6H-Benzo[d]naphtho[1,2-b]pyran-6-one,4-(6-deoxy-3-C-methyl-b-gulopyranosyl)-8-ethenyl-1-hydroxy-10,12-dimethoxy-(9CI);8-ethenyl-1-hydroxy-10,12-dimethoxy-4-(3,4,5-trihydroxy-4,6-dimethyloxan-2-yl)naphtho[1,2-c]isochromen-6-one;(+)-4-(6-Deoxy-3-C-methyl-β-D-gulo-hexopyranosyl)-8-ethenyl-1-hydroxy-10,12-dimethoxy-6H-benzo[d]naphtho[1,2-b]pyran-6-one;(+)-Virenomycin V;Chrysomycin V;Virenomycin V;4-(6-Deoxy-3-C-methyl-beta-gulopyranosyl)-8-ethenyl-1-hydroxy-10,12-dimethoxy-6H-benzo[d]naphtho[1,2-b]pyran-6-one;NSC 613946 | | CAS: | 82196-88-1 | | MF: | C28H28O9 | | MW: | 508.52 | | EINECS: | | | Product Categories: | Inhibits an EnzymeEnzyme Inhibitors by Enzyme;Topoisomerase II;A - KAntibiotics;Antibacterial;Antibiotics A to;Antibiotics A-FAntibiotics;Antibiotics by Application;Antineoplastic and Immunosuppressive AntibioticsAntibiotics;Mechanism of Action;R to;Spectrum of Activity | | Mol File: | 82196-88-1.mol |  |
| | Chrysomycin A Chemical Properties |
| Melting point | 234-236 °C | | Boiling point | 799.7±60.0 °C(Predicted) | | density | 1.405±0.06 g/cm3(Predicted) | | storage temp. | 2-8°C | | solubility | DMF: soluble | | pka | 8.55±0.20(Predicted) | | form | solid | | color | Yellow to greenish | | InChIKey | OMDANBMKOUVKAG-BMGMCLONNA-N | | SMILES | C12OC(=O)C3=C(C(OC)=CC(C=C)=C3)C=1C=C(OC)C1C(O)=CC=C(C2=1)[C@@H]1O[C@H](C)[C@H](O)[C@@](C)(O)[C@H]1O |&1:26,28,30,32,35,r| |
| | Chrysomycin A Usage And Synthesis |
| History | Chrysomycin A was first isolated from the Streptomyces A-419 strain in 1955 as a mixture of chloramphenicol A and B, and is considered one of the most promising candidates for the treatment of infections caused by multidrug-resistant Gram-positive bacteria. Strain 891, isolated from sediments in the South China Sea, has been found to yield the highest concentration of Chrysomycin A (3,600 mg/L) of all known strains under optimal conditions. | | Uses | Chrysomycin A is the major analogue in a complex of C-glycoside antitumor actives isolated from Streptomyces. Chrysomycin A, with a vinyl group in the 8-position, is the most potent analogue of the complex, and is thought to act as an inhibitor of the catalytic activity of human topoisomerase II. Chrysomycin A has a potent antibacterial, antifungal, antiviral and antitumor profile. More recent research on related metabolites, the gilvocarcins, suggests that chrysomycins may act as photoactivated cross-linkers of DNA to histones. | | Uses | Chrysomycin A is a potent antibacterial, antifungal and antiviral compound. | | Definition | ChEBI: Chrysomycin a is a glycoside. | | storage | +4°C |
| | Chrysomycin A Preparation Products And Raw materials |
|